Cervical cancer vaccines for NIP, successfully bid on SK Chemicals and Boryung

Published: 2016-06-14 13:32:09

Updated: 2016-06-14 13:32:09

The tenders for cervical cancer vaccines which will be included in the NIP from this month were settled.

Based on the result of the Public Procurement Service’s re-tenders for cervical cancer vaccines, the Korea Centers for Disease Control and Prevention announced SK Chemicals and Boryung Pharm were decided as successful bidders for Gardasil and Cervarix respectively.

3 companies, such as SK ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.